Dr. Heather Williams, MD
Claim this profileUniversity of Arkansas for Medical Sciences
Studies Gastroesophageal Junction Adenocarcinoma
Studies Skin Cancer
12 reported clinical trials
25 drugs studied
Area of expertise
1Gastroesophageal Junction Adenocarcinoma
Stage IV
Stage III
Stage II
2Skin Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
University Of Arkansas For Medical Sciences
University Of Arkansas
Clinical Trials Heather Williams, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Heather Williams, MD
Clinical Trial Related7 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Heather Williams, MD has experience with
- Carboplatin
- Cediranib Maleate
- Durvalumab
- Olaparib
- Paclitaxel
- 1:1 Peer Support
Breakdown of trials Heather Williams, MD has run
Gastroesophageal Junction Adenocarcinoma
Skin Cancer
Serous Cystadenocarcinoma
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heather Williams, MD specialize in?
Heather Williams, MD focuses on Gastroesophageal Junction Adenocarcinoma and Skin Cancer. In particular, much of their work with Gastroesophageal Junction Adenocarcinoma has involved Stage IV patients, or patients who are Stage III.
Is Heather Williams, MD currently recruiting for clinical trials?
Yes, Heather Williams, MD is currently recruiting for 6 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Heather Williams, MD has studied deeply?
Yes, Heather Williams, MD has studied treatments such as Carboplatin, Cediranib Maleate, Durvalumab.
What is the best way to schedule an appointment with Heather Williams, MD?
Apply for one of the trials that Heather Williams, MD is conducting.
What is the office address of Heather Williams, MD?
The office of Heather Williams, MD is located at: University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 United States. This is the address for their practice at the University of Arkansas for Medical Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.